Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2013

Jun 18, 2013

65122_rns_2013-06-18_e9cab60a-9070-42b6-ae8f-5d96f4b736aa.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR) ACN:[90 009 237 889 ]

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Ms Lucy Turnbull

Date of Last Notice: 17.05.2013

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.
Direct or indirect interest Direct & Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Director related entitiesTurnbull & Partners Pty Ltd
Date of change 18 June 2013
No. of securities held prior to change Options10,000,000-10,000,000
Shares Options
Direct 17,034,576 10,000,000
Indirect 725,000 -
Total 17,759,576 10,000,000
Class Listed options
Number acquired Options4,258,64468,7504,327,394
Shares Options
Direct - 4,258,644
Indirect - 68,750
Total - 4,327,394
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed Options---
Shares Options
Direct - -
Indirect - -
**Total ** - -
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation AUD 86,547.88
No. of securities held after change Options14,258,644 68,750**14,327,394 **
Shares Options
Direct 17,034,576 14,258,644
Indirect 725,000 68,750
**Total ** 17,759,576 **14,327,394 **
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestmentplan,participation in buy-back Acquiring 4,327,394 listed options at AUD 0.02each

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a company, interests which come withindisclosed in this part. paragraph (ii) of the definition of “notifiable interest of a director” should be
Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest after change

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above traded No during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?

19.06.2013

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002